更新的扣押分类2025的实用指南
Sándor Beniczky1,2,3, Eugen Trinka4,5,6, Elaine Wirrell7
1Department of Neurology, Aarhus University Hospital, Member of European Reference Network EpiCARE, Aarhus, Denmark.
Epileptic disorders : international epilepsy journal with videotape
|October 13, 2025
概括
本指南详细介绍了2025年国际抗联盟的发作分类. 它提高了诊断焦点,泛型和其他发作类型的清晰度和一致性,以更好地管理.
科学领域:
- 神经学 神经学
- 临床神经科学 临床神经科学
- 发病学 (Epileptology) 是一个专业的学科.
背景情况:
- 2017年的操作分类已经在2025年由国际抗联盟 (ILAE) 更新.
- 现有的发作分类系统需要加强,以提高临床相关性和一致性.
研究的目的:
- 为在各种临床环境中应用更新的2025年ILAE发作分类提供实用指南.
- 为了提高术语的清晰度,临床相关性和一致性.
- 支持医疗保健专业人员管理患者.
主要方法:
- 更新的分类将发作分为四个主要类别:焦点性,泛性,焦点性或泛性不明,未分类.
- 它将意识 (意识和反应能力) 作为一个分类器.
- 该分类整合了象征学,区分了可观测和不可观测的特征,并包括详细的时间和体质特征信息.
主要成果:
- 基本版本适用于资源有限的设置,而扩展版则支持高级诊断和手术决策.
- 一般性发作根据其对综合征诊断和治疗的影响而分类.
- 特别注意的是性,因为它们的独特呈现和需要紧急干预.
结论:
- 更新的ILAE分类提供了一个结构化,适应性的诊断方法.
- 实施得到了半学描述符的表格,概括性发作类型的定义和病例简介的支持.
- 本指南旨在通过在不同医疗环境中标准化发作分类来改善患者护理.
更多相关视频
相关概念视频
Seizures: Classification
1.4K
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
1.4K
Epilepsy and Seizures: Overview
1.2K
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.2K
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
822
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
822
Diagnostic and Statistical Manual of Mental Disorders (DSM)
1.1K
The Diagnostic and Statistical Manual of Mental Disorders (DSM) serves as the primary classification system for mental health disorders, providing standardized diagnostic criteria for clinicians and researchers. First published by the American Psychiatric Association (APA) in 1952, the DSM has undergone several revisions to reflect evolving psychiatric understanding. The fifth edition, DSM-5, released in 2013, introduced key updates that expanded diagnostic categories and modified diagnostic...
1.1K
Electroconvulsive Therapy
891
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
891
Antiepileptic Drugs: GABAergic Pathway Potentiators
1.2K
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
1.2K


